<cite id="su0oc"></cite><rp id="su0oc"></rp>

    1. <tt id="su0oc"></tt>

        1. <tt id="su0oc"></tt>
          <source id="su0oc"><progress id="su0oc"></progress></source>

          尼泊爾政府考慮引進中國疫苗進行臨床試驗/Govt mulls over bringing Chinese vaccine for clinical trial in Nepal

          2020年11月09日 22:44  點擊:[]


          尼泊爾政府考慮引進中國疫苗進行臨床試驗

          2020117  刊于:我的共和國

           

          加德滿都,117日訊:尼泊爾政府正考慮對中國研發的疫苗進行第三階段臨床試驗。盡管政府早在幾個月前就開始與幾家公司進行談判,但由于衛生專家對疫苗安全性的看法存在分歧,引進疫苗受到阻礙。


          尼泊爾衛生研究委員會一名官員告訴我報記者:“盡管專家們的觀點存在分歧,政府還是決定再次商洽此事,從中國引進疫苗進行臨床試驗?!?月初,國家人權委員會開始為尼泊爾針對疫情引進的疫苗投入臨床試驗做準備。國務院就該國進行臨床試驗一事與三家相關單位進行了會談。


          這位官員指出:“尼泊爾就引進疫苗一事進行后期商洽時,由于衛生專家在疫苗安全性問題上存在分歧,使得接洽事宜受阻?,F在政府再次啟動商談,將中國疫苗引進尼泊爾。政府正在討論引進克爾來福(Coronavac)——一種由中國科諾生物科技公司(Sinovac Biotech)生產的疫苗——在尼泊爾進行臨床試驗。政府一直在與該公司進行商談,以在尼泊爾進行試驗?!?科諾生物技術公司在南美和亞洲地區已開始疫苗第三階段的試驗。


          這位官員稱:“有關尼泊爾引進疫苗的具體信息將在進一步討論后公布?!闭€與一家澳大利亞公司就尼泊爾進行臨床試驗舉行了會談。一位政府官員告訴我們:“這家澳大利亞公司很樂意與我們合作,但由于在尼泊爾引進疫苗費用太高,談判一直沒有進展?!?/p>


          早些時候,國家人權委員就將牛津大學研發的疫苗防疫盾(Covidshield)引入尼泊爾進行試驗展開過討論。同樣,俄羅斯大使館前段時間也積極開展了“人造衛星-V”的第三階段臨床試驗,尼泊爾可能會使用該疫苗來防治疫情。俄羅斯大使館與政府當局就“衛星-V疫苗”的臨床試驗舉行過幾次會議,但疫苗最終沒有抵運尼泊爾。


          據《紐約時報》報道,中國科諾生物科技公司一直在準備生產一種全球適用性的疫苗,并與印度尼西亞達成協議,在2021年3月前向其供應至少4000萬劑疫苗。中國科諾生物科技公司首席執行官尹衛東在《紐約時報》上公開表示,該公司計劃2021年初在全球范圍內銷售該疫苗,包括美國。據世界衛生組織稱,在世界多個地區研發的11種疫苗正在進行第三階段臨床試驗。

          Translated by Qi Zhouqian

          Verified by Fang Lee


          Govt mulls over bringing Chinese vaccine for clinical trial in Nepal

          Published On:  November 7, 2020, at: Republica

           

          KATHMANDU, Nov 7: The government is mulling over conducting phase III clinical trials of a possible COVID-19 vaccine being developed in China in Nepal. Although the government initiated talks with several companies a few months ago, the process to bring a possible COVID-19 vaccine to Nepal was obstructed as health experts’ views were divided over the safety of the vaccine.


          “Though the experts’ views are divided, the government has again started talks to bring a vaccine developed in China to conduct clinical trials in Nepal,” an official at the Nepal Health Research Council, told Republica. Earlier in August, the NHRC had started preparations for clinical trials of investigational vaccines being developed against COVID-19 in Nepal. The Council had talked with three different companies to conduct vaccine trials in Nepal.


          “The council was in the final stage to bring vaccines in Nepal, but the move was obstructed after health experts were divided over the safety of the vaccines,” the official said, adding that now the government has again initiated talks to bring the Chinese vaccine in Nepal. “The government is holding discussions to bring in Coronavac – a vaccine produced by Sinovac Biotech – to conduct clinical trials in Nepal. The government had been continuously holding talks with the company to conduct the trials in Nepal,” the official added. The Sinovac Biotech has already started to conduct phase III trials of its vaccines in South America and Asia.


          “The detailed information about bringing the vaccine in Nepal will be disclosed after further discussions,” the official said. Likewise, the government has also been holding talks with an Australian company for conducting clinical trials in Nepal. “The Australian company is positive, but the talks have been on hold as bringing vaccines in Nepal is too expensive,” according to a government official.


          Earlier, the NHRC held discussions to bring in Covidshield — a vaccine developed by Oxford University — to conduct trials in Nepal. Likewise, the Russian Embassy earlier was also positive to conduct phase III clinical trial of “Sputnik-V” – a possible vaccine developed against COVID-19 in Nepal. The Russian Embassy held several meetings with the government authorities concerned for the clinical trial of "Sputnik-V", but the vaccine wasn’t brought to Nepal.


          According to the New York Times, Sinovac has been preparing to manufacture the vaccine for global distribution, reaching an agreement with Indonesia for the supply of at least 40 million doses by March 2021. “The company planned on worldwide distribution of the vaccine in early 2021 — including the United States,” Yin Weidong, the CEO of Sinovac, was quoted in the New York Times. According to the World Health Organization, 11 vaccines developed in several parts of the world are in the third phase of clinical trials.

           


          Link: https://myrepublica.nagariknetwork.com/news/govt-mulls-over-bringing-chinese-vaccine-for-clinical-trial-in-nepal/


          關閉

          97超人人澡高清碰碰,免费视频在线观看,日日摸夜夜摸狠狠摸,手机国产乱子伦精品视频,电影大全免费观看